Johnson & Johnson, Men's Health | featured news

Hormone Drug Slows Prostate Cancer Growth

Johnson & Johnson's drug Zytiga slowed the growth of prostate cancer in a clinical trial of men who hadn't undergone chemotherapy.

 

Subscribe to this RSS topic: Syndicate content